The University of Delaware hopes that on the other side of the COVID-19 pandemic, a brand new $150 million building will lead to the next monumental biopharmaceutical innovation. “It was a near miracle that a global pandemic was unleashed on the world, shut down the global economy, took millions of lives, and yet the bio-industry identified, developed and delivered a …